Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-039440
Filing Date
2025-05-05
Accepted
2025-05-05 07:15:49
Documents
16
Period of Report
2025-04-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0240611-8ka1_rafael.htm   iXBRL 8-K/A 42746
2 PRESS RELEASE, DATED MAY 5, 2025 ea024061101ex99-1_rafael.htm EX-99.1 15529
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2871
  Complete submission text file 0001213900-25-039440.txt   287704

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rfl-20250429.xsd EX-101.SCH 3777
5 XBRL DEFINITION FILE rfl-20250429_def.xml EX-101.DEF 26617
6 XBRL LABEL FILE rfl-20250429_lab.xml EX-101.LAB 36669
7 XBRL PRESENTATION FILE rfl-20250429_pre.xml EX-101.PRE 25241
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0240611-8ka1_rafael_htm.xml XML 5809
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K/A | Act: 34 | File No.: 001-38411 | Film No.: 25910882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)